help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gessl, A.
Right arrow Articles by Waldhäusl, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gessl, A.
Right arrow Articles by Waldhäusl, W.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 6 2204-2209
Copyright © 1998 by The Endocrine Society


Original Studies

Increased CD69 and Human Leukocyte Antigen-DR Expression on T Lymphocytes in Insulin-Dependent Diabetes Mellitus of Long Standing

Alois Gessl and Werner Waldhäusl

University of Vienna, Vienna, Austria

Address all correspondence and requests for reprints to: Alois Gessl, M.D., Division of Endocrinology and Metabolism, Department of Medicine III, University of Vienna, Währinger Gürtel 18–20, 1090 Vienna, Austria. E-mail: alois.gessl{at}akh-wien.ac.at

To better define prevailing activation of circulating T cell subsets in insulin-dependent diabetes mellitus (IDDM) of recent onset (DM; n = 31; median age ± SD,, 28 ± 6.9 yr) and of long standing (DML; n = 27; age, 33 ± 10.4 yr; median duration of disease, 105 months), CD4+ and CD8+ T cells were analyzed to determine their naive and memory subsets as well as their expression of human leukocyte antigen (HLA)-DR, interleukin-2 receptor {alpha}-chain (CD25), and CD69 by three-color flow cytometry. Twenty-six healthy subjects (HS; age, 32.0 ± 8.2 yr) served as controls.

No deviation was seen in either IDDM group compared to HS in CD25 expression on CD4+ or CD8+ cells or in their CD45RA+ or CD45RA- subsets. HLA-DR expression, however, was increased (P < 0.05) in total CD8+ cells and CD45RA+ cells, with CD45RA- CD8+ cells joining the prevailing pattern only in DML. Among CD4+ cells, increased expression of HLA-DR molecules was restricted to total and CD45RA- cells in DML. CD69 expression did not differ between IDDM and HS, but differed between DML (CD4+, CD8+, and CD45RA- CD4+) and DM only.

In conclusion, our data demonstrate that HLA-DR expression in IDDM is restricted to memory cells (CD45RA-) among CD4+ cells in DML and is more markedly confined to naive (CD45RA+) than to memory CD8+ cells, whereas the early activation antigen CD69 is more readily expressed in DML than in DM. The observed activation of circulating T cells suggests an ongoing immune process in IDDM both at clinical manifestation and after long duration.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Gomez, S. M. Sanz-Gonzalez, Y. N. A. Nabah, A. Lamana, F. Sanchez-Madrid, and V. Andres
Atherosclerosis development in apolipoprotein E-null mice deficient for CD69
Cardiovasc Res, January 1, 2009; 81(1): 197 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Battaglia, A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M.-G. Roncarolo
Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients
J. Immunol., December 15, 2006; 177(12): 8338 - 8347.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A Suarez, P Lopez, J Gomez, and C Gutierrez
Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids
Ann Rheum Dis, November 1, 2006; 65(11): 1512 - 1517.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Lindley, C. M. Dayan, A. Bishop, B. O. Roep, M. Peakman, and T. I.M. Tree
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Diabetes, January 1, 2005; 54(1): 92 - 99.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. Ernerudh, J. Ludvigsson, G. Berlin, and U. Samuelsson
Effect of Photopheresis on Lymphocyte Population in Children with Newly Diagnosed Type 1 Diabetes
Clin. Vaccine Immunol., September 1, 2004; 11(5): 856 - 861.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. P. L. Chiu, A. M. Jevnikar, and J. S. Danska
Genetic Control of T and B Lymphocyte Activation in Nonobese Diabetic Mice
J. Immunol., December 15, 2001; 167(12): 7169 - 7179.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Ottendorfer, T. M. Ellis, K. S. Bahjat, M. Clare-Salzler, and M. A. Atkinson
No Alteration in T Lymphocyte Expression of CD40 Ligand (CD154) in Individuals with or at Increased Risk for Insulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4068 - 4072.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society